Rate My Professor Charlotte Teneback

Teneback's research expertise encompasses cystic fibrosis, non-cystic fibrosis bronchiectasis, and general pulmonary medicine. She has contributed to key publications, including 'Lung Function and Microbiota in Cystic Fibrosis' in Microbiome (2020), 'Risk of Readmission and Mortality Following Hospitalization with Hypercapnic Respiratory Failure' in Lung (2020), and chapters on disease-specific approaches in pulmonary rehabilitation (2018) and COPD in Critical Care Secrets (6th edition, 2018). Recent works include investigations into nontuberculous mycobacteria in cystic fibrosis patients, personalized inhaled bacteriophage therapy for resistant Pseudomonas aeruginosa infections (Nature Medicine, 2025), and multi-dimensional phenotyping of adult cystic fibrosis cohorts (Journal of Cystic Fibrosis, 2021). She co-authored the book Bronchiectasis (Springer, 2022). Teneback was recognized as a winner in the Dean's Celebration of Excellence in Research. She leads clinical trials improving cystic fibrosis treatments and directs the accredited Adult Cystic Fibrosis Program at the University of Vermont Medical Center, contributing to advancements in respiratory microbiota remodeling and infection management in cystic fibrosis patients. She delivers seminars on cystic fibrosis care in Northern New England.